Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TiaoBuFeiShen capsule versus placebo for stable chronic obstructive pulmonary disease
ChiCTR-TRC-13003947Phase 2Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Aug 2007
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TiaoBuFeiShen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: blood routine examination, routine urine test and 11 more. Started Aug 2007; status: completed.
02
Drugs
TiaoBuFeiShen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003947.